Glenmark Pharma’s arm recalls 98,307 packs of Mometasone Furoate Topical Solution

25 Jul 2022 Evaluate

Glenmark Pharmaceuticals’ fully owned subsidiary -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is recalling 98,307 packs of Mometasone Furoate Topical Solution, a medication used to treat skin conditions such as eczema, psoriasis, allergies, and rash. The company is recalling the lot, which rolled out from the company's Baddi (Himachal Pradesh) plant, due to Defective Container.

The company initiated the nationwide recall, which the US health regulator classified as Class III, on June 16, 2022. A Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. The US generic drug market was estimated to be around $115.2 billion in 2019. It is by far the largest market for pharmaceutical products in the world.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

2025.40 -10.50 (-0.52%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×